We have our own independent quality control system and devote significant attention to quality control of the design, manufacturing and testing of our products. Our stringent product quality control starts from the research and development stage. Our laboratories are operated by highly educated and skilled technicians to ensure quality of all released batches of our products. We have established detailed quality control procedures guiding our internal production and external purchase of drugs and other materials used in our research experiments. To ensure high product quality, we have implemented a “quality-by-design” approach pursuant to which manufacturing processes are designed during the product development stage and quality control processes are continuously monitored.


Shenyang Manufacturing

Our main manufacturing facilities are located in the Shenyang Economy & Technology Development Zone. Our facilities in Shenyang are capable of bulk production of mammalian cell-based proteins and bacterial cell-based proteins, as well as formulation of final products. Our manufacturing facilities are equipped with state-of-art equipment supplied by top brands, such as bioreactors, centrifuges, chromatography systems, finish and fill lines and lyophilizers. In 2013, our mammalian cell-based production plant and bacterial cell-based production plant were both certified under the latest edition of the Chinese GMP by the CFDA.

 Shanghai Manufacturing

In 2016 3SBio completed the acquisition of Shanghai CP Guojian, China's largest monoclonal antibody production facility and now renamed Sunshine Guojian. Sunshine Guojian currently operates five antibody production lines with a total annual capacity of over 8,000 liters. Six new antibody production lines with a total annual capacity of 30,000 liters are currently under trial run, for a total 38,000L of production capacity.

 Hangzhou Manufacturing

Zhejiang Wansheng Pharmaceuticals Co. Ltd was acquired in 2015 and is the group's platform for R&D and manufacturing of chemically synthesized drugs. Zhejiang Wansheng has 11 GMP-compliant production lines capable of producing various drug delivery formats, including tablets, capsules, TCM granules, injections, tinctures, ointments and lotions.

Shenzhen Manufacturing

In December 2014, we acquired Sciprogen, together with its manufacturing facilities in Shenzhen. We manufacture SEPO and Sparin in our Shenzhen facilities. In 2013, Sciprogen’s Shenzhen production plant was certified under the latest Chinese GMP.


Como Manufacturing

In December 2014, we acquired Sirton, together with its manufacturing facilities in Como, Italy. Our Como facilities are authorized to manufacture injectable pharmaceutical products in various formats including pre-filled syringes, lyophilized vials, liquid vials and ampoules. In 2014, our Como facilities were granted a GMP certificate for the production of human medicinal products by the Italian Medicines Agency


Dongguan Manufacturing (under construction)

We have started constructing new manufacturing facilities in Dongguan, Guangdong to expand our production capacities of SEPO and Sparin.